The Pilot Randomized Study of Nesiritide Versus Dobutamine in Heart Failure (PRESERVD-HF)
Open Access
- 19 September 2005
- journal article
- research article
- Published by Elsevier BV in The American Journal of Cardiology
- Vol. 96 (6), 18-25
- https://doi.org/10.1016/j.amjcard.2005.07.017
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- Overview of Current Noninodilator Therapies for Acute Heart Failure SyndromesThe American Journal of Cardiology, 2005
- Reassessment of Dobutamine, Dopamine, and Milrinone in the Management of Acute Heart Failure SyndromesThe American Journal of Cardiology, 2005
- Minor myocardial damage detected by troponin T is a powerful predictor of long-term prognosis in patients with acute decompensated heart failureInternational Journal of Cardiology, 2005
- Biochemical markers of myocyte injury in heart failureHeart, 2004
- Organized program to initiate lifesaving treatment in hospitalized patients with heart failure (OPTIMIZE-HF): rationale and designAmerican Heart Journal, 2004
- Usefulness of an elevated troponin-I in predicting clinical events in patients admitted with acute heart failure and acute coronary syndrome (from the RITZ-4 trial)The American Journal of Cardiology, 2004
- Implications of elevated cardiac troponin t in ambulatory patients with heart failure: a prospective analysisAmerican Heart Journal, 2004
- Prognostic Value of Combination of Cardiac Troponin T and B-Type Natriuretic Peptide after Initiation of Treatment in Patients with Chronic Heart FailureClinical Chemistry, 2003
- Efficacy and safety of intravenous levosimendan compared with dobutamine in severe low-output heart failure (the LIDO study): a randomised double-blind trialThe Lancet, 2002
- Effect of Short-Term Infusion of Sodium Nitroprusside on Mortality Rate in Acute Myocardial Infarction Complicated by Left Ventricular FailureNew England Journal of Medicine, 1982